Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
From the official U.S. FDA label for amitriptyline hydrochloride, the active ingredient registered with NAFDAC.
For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than are other depressive states.
Within each category the following adverse reactions are listed in order of decreasing severity. Included in the listing are a few adverse reactions which have not been reported with this specific drug. However, pharmacological similarities among the tricyclic antidepressant drugs require that each of the reactions be considered when amitriptyline is administered. Cardiovascular: Myocardial infarction; stroke; nonspecific ECG changes and changes in AV conduction; heart block; arrhythmias; hypotension, particularly orthostatic hypotension; syncope; hypertension; tachycardia; palpitation. …
Amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. It should not be given concomitantly with monoamine oxidase inhibitors. Hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. …
Clinical Worsening and Suicide Risk Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs. Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide. …
Add the expiry date on your pack for a full Trust Score.
Joncine Tablets contains Amitriptyline Hydrochloride (25 mg), as tablet, according to its NAFDAC registration record.
Yes. Joncine Tablets is listed on the NAFDAC register under registration number A4-6551, and its registration is active as of 27 October 2026.
No WHO falsified or substandard medical product alert currently matches Joncine Tablets in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A4-6551, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than are other depressive states. (Summarised from the official U.S. FDA label for amitriptyline hydrochloride. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.